Using target trial emulation to study GLP-1s and alcohol-related hospitalizations

By Emma Holler, PhD, MPH , Sr. Applied Research Scientist at Truveta I’m excited to share new research from our team examining whether newer GLP-1 receptor agonists may be associated with fewer alcohol-related hospital visits among people with alcohol use disorder (AUD). Interest in the potential effects of GLP-1 medications on alcohol use has grown rapidly, but rigorous evidence is still limited.